Dose–Volume Metrics Associated With Radiation Pneumonitis After Stereotactic Body Radiation Therapy for Lung Cancer-Reference-Cited by-同舟云学术

Dose–Volume Metrics Associated With Radiation Pneumonitis After Stereotactic Body Radiation Therapy for Lung Cancer

Published:2012-07 Issue:4 Volume:83 Page:e545-e549
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Matsuo Yukinori,Shibuya Keiko,Nakamura Mitsuhiro,Narabayashi Masaru,Sakanaka Katsuyuki,Ueki Nami,Miyagi Ken,Norihisa Yoshiki,Mizowaki Takashi,Nagata Yasushi,Hiraoka Masahiro

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference20 articles.

1. Stereotactic body radiation therapy for inoperable early stage lung cancer;Timmerman;JAMA,2010

2. A phase II trial of stereotactic body radiation therapy for operable T1N0M0 non-small cell lung cancer: Japan Clinical Oncology Group (JCOG0403);Nagata;Int J Radiat Oncol Biol Phys,2010

3. Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-cell lung cancer: A population-based time-trend analysis;Palma;J Clin Oncol,2010

4. Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer—a first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study;Baumann;Radiother Oncol,2008

5. Exceptionally high incidence of symptomatic grade 2-5 radiation pneumonitis after stereotactic radiation therapy for lung tumors;Yamashita;Radiat Oncol,2007

Cited by 163 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel predictor for dosimetry data of lung and the radiation pneumonitis incidence prior to SBRT in lung cancer patients;Scientific Reports;2024-08-11

2. Two-Part Mixed Effects Mixture Model for Zero-Inflated Longitudinal Compositional Data;Journal of the Indian Society for Probability and Statistics;2024-07-03

3. The potential of integrating stereotactic ablative radiotherapy techniques with hyperfractionation for lung cancer;Thoracic Cancer;2024-06-17

4. Stereotactic ablative radiotherapy (SABR) for patients with lung tumor and severe pulmonary function impairment;Clinical and Translational Oncology;2024-06-13

5. Improvement of Prediction Performance for Radiation Pneumonitis by Using 3-Dimensional Dosiomic Features;Clinical Lung Cancer;2024-06